Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
收藏数据链接：
官方服务：
资源简介：
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002, mandating FDA performance goals in reviewing and acting on drug applications within specified time periods. In turn, the FDA was permitted to levy user fees on drug sponsors submitting
提供机构：
美国国家经济研究局创建时间：
2004-10-01
